Right Turn: Signals’ Top 10 most popular blogs of 2022

Last week bloggers Cal Strode and Tannen Horber shared their favourite blogs from the past year, and I wondered whether there would be any overlap in the Top 10 list below where the number of readers for each post dictates who makes the cut. The answer is “yes.” One of Cal’s favourites was the post about Emily Whitehead (“Right Turn: Celebrating a monumental anniversary”) and it made this list too, which isn’t a surprise to me given how many “likes” it also received when it was promoted on social media. It takes the number one spot for most popular CCRM LinkedIn posts of all time.

Based on the choices below, I would surmise that there were a lot of academics – and I’d go further and say grad students – reading Signals this year (see the #1 pick), as well as people curious about CCRM’s new subsidiary OmniaBio Inc. (coming in at #3 is “Meet Mitch”) and there’s an appetite for information about biomanufacturing (with two posts below, plus the aforementioned OmniaBio post).

If you have missed any of these blog posts, why not catch up now? Are they also your favourites? Please let us know in the comments below. Also, please subscribe if you haven’t already.

A big thank you to our contributing bloggers this year and to all of you for reading along! You are the reason why we publish Signals. Wishing you happy holidays and all the best for 2023!

1. Moving from academia to industry – one postdoc’s experience by Josh Dierolf.
2. An immune system and cancer immunotherapy primer by Sara M. Nolte
3. Meet Mitch: The CEO leading Canada’s largest CDMO dedicated to manufacturing for CGTs by Cal Strode
4. Takeaway from CDL-CCRM event: Are smart cells the next generation of natural drugs? by Leili Rohani and Stephanie Willerth
5. Reflecting on and recapping ComSciConCAN 2022 by Francesco Zangari and the event’s organizing committee
6. Catching up with ExCellThera and co-founder Guy Sauvageau by Cal Strode
7. Right turn: Celebrating a monumental anniversary by Stacey Johnson
8. Right turn: Canada’s biomanufacturing capabilities are growing by Stacey Johnson
9. Stem cell sweethearts: controlling blood sugar and heartbeats at TMM 2022 by Kevin Robb
10. Right Turn: Experts weigh in on manufacturing of CGTs at JLABS-CCRM event by Stacey Johnson

Here is some music to listen to while you are reading.

The following two tabs change content below.

• Bio
• Latest Posts

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.

Latest posts by Stacey Johnson (see all)

• Right Turn: #pinksocks, diabetes news and other ramblings - June 24, 2025
• Right Turn: Some takeaways from Advanced Therapies Week 2025 - January 31, 2025
• Right Turn: The top 10 most-read blog posts in 2024 - January 2, 2025